Connection
Michelle Leppert to Cost-Benefit Analysis
This is a "connection" page, showing publications Michelle Leppert has written about Cost-Benefit Analysis.
|
|
Connection Strength |
|
|
|
|
|
0.915 |
|
|
|
-
Leppert MH, Poisson SN, Carroll JD, Thaler DE, Kim CH, Orjuela KD, Ho PM, Burke JF, Campbell JD. Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention. Stroke. 2018 06; 49(6):1443-1450.
Score: 0.504
-
Leppert MH, Campbell JD, Simpson JR, Burke JF. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke. Stroke. 2015 Jul; 46(7):1870-6.
Score: 0.411